Are you Dr. Cooper?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1100 Van Ness Ave
San Francisco, CA 94109Phone+1 415-600-1000Fax+1 415-558-7051
Summary
- Dr. Stewart Cooper, MD is a gastroenterologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with California Pacific Medical Center and Alta Bates Summit Medical Center-Alta Bates Campus.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 1999 - 2002
- The University of Wales College of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 2003 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Hepatitis B Research Network Adult Cohort Study Start of enrollment: 2010 Dec 01
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B Start of enrollment: 2011 Feb 01
- Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 648 citationsAnalysis of a successful immune response against hepatitis C virusStewart Cooper, Ann L. Erickson, Erin J. Adams, Joe Kansopon, Amy J. Weiner
Immunity. 1999-04-01 - 245 citationsAcute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and ReinfectionKimberly Page, Judith A. Hahn, Jennifer L. Evans, Stephen Shiboski, Paula J. Lum
The Journal of Infectious Diseases. 2009-10-01 - 186 citationsOral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.Christopher Koh, Laetitia Canini, Harel Dahari, Xiongce Zhao, Susan L. Uprichard
The Lancet. Infectious Diseases. 2015-10-01